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Abstract
Background: Acute flaccid paralysis (AFP) surveillance has been adopted globally as a key strategy for monitoring
the progress of the polio eradication initiative. Hereby, to evaluate the completeness of the ascertainment of AFP
cases in Italy, a hospital-discharges based search was carried out.
Methods: AFP cases occurring between 2007 and 2016 among children under 15 years of age were searched in the
Italian Hospital Discharge Records (HDR) database using specific ICD-9-CM diagnostic codes. AFP cases identified
between 2015 and 2016 were then compared with those notified to the National Surveillance System (NSS).
Results: Over a 10-year period, 4163 hospital discharges with diagnosis of AFP were reported in Italy. Among these,
956 (23.0%) were acute infective polyneuritis, 1803 (43.3%) myopathy, and 1408 (33.8%) encephalitis, myelitis and
encephalomyelitis. During the study period, a decreasing trend was observed for all diagnoses and overall the annual
incidence rate (IR) declined from 5.5 to 4.5 per 100,000 children. Comparing NSS with HDR data in 2015–2016, we
found a remarkable underreporting, being AFP cases from NSS only 14% of those recorded in HDR. In particular, the
acute infective polyneuritis cases reported to NSS accounted for 42.6% of those detected in HDR, while only 0.9% of
myopathy cases and 13.1% of encephalitis/myelitis/encephalomyelitis cases have been notified to NSS. The highest
AFP IRs per 100,000 children calculated on HDR data were identified in Liguria (17.4), Sicily (5.7), and Veneto (5.1)
Regions; regarding the AFP notified to the NSS, 11 out of 21 Regions failed to reach the number of expected cases
(based on 1/100,000 rate), and the highest discrepancies were observed in the Northern Regions. Overall, the national
AFP rate was equal to 0.6, therefore did not reach the target value.
Conclusions: AFP surveillance data are the final measure of a country’s progress towards polio eradication. The
historical data obtained by the HDR have been useful to assess the completeness of the notification data and to
identify the Regions with a low AFP ascertainment rate in order to improve the national surveillance system.
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Background
The World Health Organization (WHO) recommends
countries to monitor cases of acute flaccid paralysis (AFP),
which is the main clinical picture of a poliovirus infection,
and the poliovirus (PV) circulation, to provide accurate
data for the development of appropriate prevention and
control strategies [1]. An important prerequisite for polio-
free certification is that the National Surveillance System
(NSS) successfully detects annually at least one case of
non-polio associated AFP per 100,000 children under 15
years of age and no cases of wild polio occur for three
consecutive years [1, 2]. The adequacy and quality of the
AFP surveillance are assessed by the following key indica-
tors recommended by the WHO: completeness of report-
ing, geographical and demographic representativeness of
reporting sites, sensitivity of surveillance, completeness of
case investigations and follow-up, laboratory performance
[1]. Although low levels of PV transmission have been re-
ported in recent years, the virus is still endemic in Nigeria,
Afghanistan, and Pakistan. Until the PV transmission is
not interrupted, all countries remain at risk of virus im-
portation, through population movements. Indeed, polio
eradication is hampered by the international spread of
poliovirus through travellers. In response to the ongoing
importations of poliovirus in polio-free countries, the
WHO Director General on 5th May 2014 declared the
international spread of wild poliovirus to be a public
health emergency of international concern [3].
In Italy, AFP surveillance was established in 1994, ac-
cording to the WHO guidelines, but started in January
1996 as a pilot study on four Italian Regions, and was fi-
nally extended to the whole nation in 1997. The Italian
National Institute of Health (Istituto Superiore di Sanità
– ISS) and the Ministry of Health (MoH) coordinate the
national AFP surveillance system including 20 Regional
Reference Centres (RRC).
Acute flaccid paralysis is defined as any case of new onset
of hypotonic weakness in a child younger than 15 years of
age and includes possible diseases due to paralytic poliomy-
elitis, Guillain-Barré Syndrome (GBS), transverse myelitis,
polyradiculoneuritis, traumatic and neoplastic neuritis [4].
The present study aims to investigate the number of
AFP cases reported from 2007 to 2016 in the Hospital
Discharge Records (HDRs). These data were then com-
pared with those obtained by the NSS in 2015 and 2016
for each Italian Region, in order to assess the complete-
ness of reporting to the surveillance system.
Methods
Data sources
Hospital discharge records
All the hospitalizations made in public and private Ital-
ian hospitals are routinely collected in the HDR data-
base, a systematic data collection on health care at
national level, including both demographic and clinical
information, such as primary and secondary diagnoses,
primary and secondary diagnostic/therapeutic proce-
dures, type of discharge, and hospital length of stay [5].
Diagnoses and procedures are coded using the “Inter-
national Classification of Diseases, 9th Revision, Clinical
Modification” (ICD-9-CM).
We selected hospital discharges, among children aged
less than 15 years, due to AFP based on the following
ICD-9-CM codes as indicated in primary or secondary
diagnoses [6]:
045.0X “Acute paralytic poliomyelitis specified as
bulbar”
045.1X “Acute poliomyelitis with other paralysis”
357.0 “Acute infective polyneuritis” (approximates
GBS)
359.9 “Myopathy, unspecified” (approximates
Flaccid paralysis)
323.9 “Unspecified causes of encephalitis, myelitis,
and encephalomyelitis” (approximates Acute transverse
myelitis)
The Italian National Surveillance System for AFP
The active surveillance system was established at a na-
tional level in 1997, and it is coordinated by the ISS
hosting the WHO collaborative centre for reference and
research on polio. All AFP notifications included clinical
and laboratory information and followed-up for residual
paralysis at 60–90 days to ensure that the cases were not
due to PV [4]. In particular, according to the WHO-
recommended surveillance standard of poliomyelitis, the
following criteria were considered:
clinical case definition: any child under 15 years of
age with AFP or any person of any age with paralytic
illness if polio is suspected;
case classification: suspected case (meets the clinical
case definition) or confirmed case (presence of
poliovirus in stool samples).
For all notified AFP to the RRC, stool samples were
collected for laboratory confirmation. After 60 days from
case notification, a follow-up questionnaire with more
detailed information has to be sent to ISS and MoH to
clarify the conclusive diagnosis. A first performance indi-
cator is the number of AFP cases not due to polio per
100,000 children < 15 years of age per year, which is in-
dicative of the sensitivity of the surveillance system (≥1/
100,000). A second indicator is the proportion of AFP
cases (≥80%) for which stool specimens in “good” condi-
tions were collected [7].
According to the national regulation, ethics approval
was not required as clinical isolates were collected,
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processed, and stored as part of routine clinical care by
the hospital laboratories participating in the network.
The surveillance activities are required by the Global
Polio Eradication Initiative (GPEI) of the WHO in the
“Polio Eradication & Endgame Strategic Plan 2013-
2018”, and by the Italian Ministry of Health (ref.
0004114–08/02/2018-DGPRE-DGPRE-P).
Data used for our study was not publically available.
Statistical analysis
All the HDRs between 1st of January 2005 and 31st of
December 2016 were extracted from the MoH database.
We considered the first hospital admission in case the
same patient experienced more than one event, and then
we excluded all hospitalization events occurring in the
years 2005 and 2006, in order to exclude patients with
sequelae from previous AFP discharges.
The number of hospitalizations, both overall and by
specific diagnostic codes, and the AFP incidence rates
were summarized by calendar year, gender, age groups,
and geographical area (i.e., Northern, Central, and
Southern Italy, based on the Italian National Institute of
Statistics classification – ISTAT).
For the comparison between HDR and NSS data, we
focused on the last 2 years of the considered period,
2015–2016, to study in-depth not only the differences
between the two databases for each Italian Region, but
also to highlight the discrepancies among Regions and
how those vary in the latest data available year. There-
fore, the absolute number and incidence rates (IR) of
AFP coming from HDR data were calculated for each
Region and compared with those reported by the NSS in
the same period. Moreover, differences between the
number of reported and expected cases notified to the
NSS were calculated, to show the degree to which a Re-
gion was over or under the target value.
Statistical analysis was performed using the Stata soft-
ware, version 13 (Stata Cooperation, College Station,
Texas, USA).
Results
We identified 4163 hospital events with a diagnosis
compatible with AFP between 2007 and 2016 in Italy.
Most cases were clinically diagnosed as unspecified my-
opathy (1803, 43.3%), followed by encephalitis/myelitis/
encephalomyelitis (1408, 33.8%), and acute infective
polyneuritis (956, 23.0%) (Table 1). A decreasing trend
was observed for all diagnoses during the study period,
and overall the annual AFP incidence rate (IR) declined
from 5.5 to 4.5 per 100,000 children. In addition, the
proportion of the three main diagnoses out of the total
AFP cases for each calendar year remained quite stable
over time. It is of note that 3 “Acute paralytic poliomyel-
itis specified as bulbar” cases (2 cases 045.00 unspecified
type poliovirus, 1 case 045.02 poliovirus type I), and 1
“Acute poliomyelitis with other paralysis” case (045.10
unspecified type poliovirus) were incorrectly coded as
ascertained after an investigation of ISS and MoH on
medical records. A single vaccine-associated event, oc-
curred in an Albanian subject before his arrival in Italy
in 2014, was recorded as “Acute poliomyelitis with other
paralysis, poliovirus type III”.
Table 2 shows the main characteristics of the AFP
cases among children aged 0–14 years reported in HDR
database in the last 2 years of the study period, 2015–
2016. Females were less frequently affected by AFP as
compared to males [incidence rate ratio (IRR) 0.7/100,
000], and fewer cases of AFP were recorded among chil-
dren aged 5–9 and 10–14 years compared to those aged
0–4 years (IRR 0.6 and 0.5 per 100,000). In addition,
small differences in the AFP incidence rates were found
among the three geographic areas, as the Central and
Southern Italy compared to Northern Italy (the most
populated area, and with more hospital services in the
paediatric setting) reported an IRR of 0.9 and 0.8, re-
spectively. Similar patterns of AFP types were observed
in all geographic areas. The most common cause of AFP
cases was myopathy (IR 1.9/100,000), followed by en-
cephalitis/myelitis/encephalomyelitis (IR 1.4/100,000)
and acute infective polyneuritis (0.9/100,000).
The AFP cases from HDR were compared to those re-
ported to the NSS in 2015–2016, analysing data from
each of the 20 Italian Regions (Trentino-Alto Adige Re-
gion is formed by Bolzano and Trento Autonomous
Provinces) (Table 3). Twelve cases notified to the NSS
were not included in the analysis, because they did not
fit with the considered ICD-9-CM specific codes. Major
AFP IR (per 100,000 children) coming from HDR data
were detected in Liguria (17.4), Sicily (5.7) and Veneto
(5.1), whereas the lowest values were recorded in Um-
bria (0.4) and Molise (1.4) (Fig. 1a). Of note, the highest
percentages of hospitalization among non-residents were
recorded in Liguria and Lazio Regions, nearly 64 and
40% respectively, indicating an interregional mobility.
Regarding the AFP notified to the NSS, the complete-
ness of reporting varied by Regions. Considering the dif-
ference between the number of reported and expected
cases (based on 1/100,000 rate), 11 out of 21 Regions
failed to achieve the target (values < 0), and the highest
discrepancies were observed in the Northern Regions
(Lombardy, Emilia-Romagna, Tuscany, and Piedmont)
(Fig. 1b). Campania, Lazio and Calabria were over the
expected value (difference > 0), while for 7 Regions no
difference was found.
Overall, the total number of AFP cases from NSS in
Italy did not reach the expected value, which is nearly 83
cases considering an Italian population aged under 15
years of 8,300,000. In 2015–2016, AFP cases from NSS
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Table 2 Demographic and clinical characteristics of Acute Flaccid Paralysis cases, Italy 2015–2016
AFP = 713 Number Percent IR IRR 95% CI IRR
Gender
Male 430 60.3 5.0 –
Female 283 39.7 3.5 0.7 0.6–0.8
Class of age (years)
0–4 322 45.2 6.2 –
5–9 198 27.8 3.5 0.6 0.5–0.7
10–14 193 27.1 3.4 0.5 0.5–0.7
Nationality
Italian 627 87.9 4.2 –
Other 86 12.1 4.6 1.1 0.9–1.4
Geographic area
North 357 50.1 4.7 –
Centre 132 18.5 4.1 0.9 0.7–1.1
South 224 31.4 3.8 0.8 0.7–1.0
Clinical characteristics
Acute infective polyneuritis (357.0) 155 21.7 0.9 –
Myopathy, unspecified (359.9) 323 45.2 1.9 2.1 1.7–2.6
Unspecified causes of encephalitis, myelitis, and encephalomyelitis (323.9) 236 33.1 1.4 1.6 1.3–1.9
Data were extracted from Hospital Discharge Records [5]
Italian population data were obtained from ISTAT database (www.demo.istat.it)
357.0 code approximates Guillain-Barré Syndrome; 359.9 code approximates Flaccid paralysis; 323.9 code approximates Acute transverse myelitis
AFP acute flaccid paralysis, IR incidence rate × 100,000 population, IRR incidence rate ratio, CI confidence interval
Table 1 Acute flaccid paralysis cases and incidence rates, Italy 2007–2016
ICD-9-CM diagnosis codes 045.0 045.1 357.0 359.9 323.9
Year AFP IR N % N % N % N % N %
2007 457 5.5 0 0.0 0 0.0 117 25.5 171 37.3 169 36.9
2008 463 5.5 0 0.0 0 0.0 95 20.5 217 46.9 152 32.8
2009 473 5.6 0 0.0 0 0.0 101 21.3 196 41.4 176 37.1
2010 434 5.1 0 0.0 0 0.0 110 25.2 195 44.7 130 29.8
2011 443 5.2 0 0.0 0 0.0 113 25.5 190 42.9 140 31.6
2012 412 4.9 0 0.0 0 0.0 88 21.4 171 41.5 155 37.6
2013 378 4.5 0 0.0 0 0.0 84 22.2 174 46.0 120 31.7
2014 390 4.6 0 0.0 1 0.3 93 23.8 166 42.6 130 33.3
2015 339 4.0 0 0.0 0 0.0 62 18.3 162 47.8 116 34.2
2016 374 4.5 0 0.0 0 0.0 93 24.9 161 43.0 120 32.1
2007–2016 4163 5.0 0 0.0 1 0.0 956 23.0 1803 43.3 1408 33.8
Data were extracted from Hospital Discharge Records [5]
Italian population data were obtained from ISTAT database (www.demo.istat.it)
Five cases presented more than one diagnosis
ICD-9-CM diagnosis codes: 045.0 “Acute paralytic poliomyelitis specified as bulbar“;
045.1 “Acute poliomyelitis with other paralysis“; 357.0 “Acute infective polyneuritis”;
359.9 “Myopathy, unspecified”; 323.9 “Unspecified causes of encephalitis, myelitis, and encephalomyelitis”
357.0 code approximates Guillain-Barré Syndrome; 359.9 code approximates Flaccid paralysis; 323.9 code approximates Acute transverse myelitis
AFP acute flaccid paralysis, IR incidence rate × 100,000
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were 14% of those obtained by HDR data, indicating a
high level of underreporting at a national level. Specific-
ally, only 42.6% of acute infective polyneuritis cases,
13.1% of encephalitis/myelitis/encephalomyelitis cases,
and 0.9% of myopathy cases reported in HDR were noti-
fied to the NSS.
Discussion
The present study aimed to evaluate the AFP surveil-
lance system over a 10-year period in Italy by comparing
data obtained from HDR with those from NSS in the last
2 years by each Italian region. The comparison indicates
that NSS data are affected by underreporting, since the
AFP cases from NSS were only 14% of those recorded in
HDR during the years 2015–2016. Specifically, the per-
centage of notified cases differs by clinical diagnosis be-
ing almost absent for unspecified myopathies (359.9
ICD-9-CM code), and very low for encephalitis/myelitis/
encephalomyelitis with unspecified causes (323.9 ICD-9-
CM code), while GBS cases (included in 357.0 ICD-9-
CM code) have been notified. Even the underreporting
exists, the NSS still plays a crucial role in identifying
AFP cases that would remain undetected due to the dis-
advantage of HDRs, since they have the limitation that is
not based on specific case definitions, and therefore not
extremely accurate. This is demonstrated by coding er-
rors for the discharge diagnoses of four not confirmed
cases of poliomyelitis, lacking the requirement for a
laboratory-based confirmation.
Although poliomyelitis has historically been respon-
sible for most cases of flaccid paralysis infection-
related, non-polio enteroviruses were well known to be
associated with AFP/Acute Flaccid Myelitis (AFM) [8].
In particular, enterovirus D68 (EV-D68) has become in-
creasingly recognized in the context of enhanced sur-
veillance for polio-like diseases [9]. Large outbreaks of
EV-D68 occurred in the United States, Canada, and
Europe in 2014 and 2016, temporally and geographic-
ally associated with an increase in AFM [10]. During
2018, the United Kingdom described an increase in re-
ports of AFP cases, with many cases diagnosed as the
AFM occurred mainly among preschool children [11].
Table 3 Acute Flaccid Paralysis cases and incidence rates: comparison between Hospital Discharge Records and National
Surveillance System, Italy 2015–2016
Regions AFP 2015 357.0 359.9 323.9 AFP 2016 357.0 359.9 323.9
HDR HDR IR NSS NSS IR HDR NSS HDR NSS HDR NSS HDR HDR IR NSS NSS IR HDR NSS HDR NSS HDR NSS
Piedmont 19 3.3 3 0.5 4 3 7 0 8 0 27 4.8 5 0.9 3 2 11 2 13 1
Valle d’Aosta 1 5.6 0 0.0 1 0 0 0 0 0 0 0.0 0 0.0 0 0 0 0 0 0
Lombardy 60 4.2 4 0.3 10 2 28 0 22 2 57 4.0 14 1.0 15 8 25 0 17 6
A.P. Bolzano 0 0.0 0 0.0 0 0 0 0 0 0 5 6.0 3 3.6 3 3 1 0 1 0
A.P. Trento 1 1.2 1 1.2 1 1 0 0 0 0 3 3.8 1 1.3 1 1 1 0 1 0
Veneto 33 4.8 3 0.4 4 3 16 0 13 0 37 5.4 10 1.5 10 9 12 0 15 1
Friuli-Venezia Giulia 3 1.9 0 0.0 1 0 2 0 1 0 4 2.6 0 0.0 2 0 2 0 0 0
Liguria 35 19.2 0 0.0 2 0 28 0 5 0 28 15.6 1 0.6 2 1 22 0 4 0
Emilia-Romagna 13 2.2 4 0.7 4 2 5 0 4 2 31 5.2 1 0.2 11 0 10 0 10 1
Tuscany 23 4.8 0 0.0 1 0 14 0 8 0 14 2.9 3 0.6 3 3 8 0 3 0
Umbria 0 0.0 1 0.9 0 0 0 0 0 1 1 0.9 0 0.0 0 0 1 0 0 0
Marche 8 3.9 1 0.5 3 0 3 0 2 1 10 5.0 1 0.5 3 0 6 0 1 1
Lazio 41 5.0 2 0.2 10 2 26 0 5 0 35 4.3 5 0.6 10 3 19 0 6 2
Abruzzi 6 3.5 2 1.2 1 1 1 0 4 1 7 4.1 0 0.0 1 0 2 0 4 0
Molise 1 2.7 0 0.0 0 0 0 0 1 0 0 0.0 0 0.0 0 0 0 0 0 0
Campania 16 1.8 7 0.8 6 4 7 0 3 3 20 2.2 0 0.0 5 0 10 0 5 0
Apulia 22 3.8 5 0.9 2 5 7 0 13 0 27 4.8 8 1.4 9 3 6 0 11 5
Basilicata 2 2.7 0 0.0 0 0 1 0 1 0 1 1.4 0 0.0 0 0 0 0 1 0
Calabria 7 2.6 1 0.4 3 1 2 0 2 0 13 4.8 0 0.0 4 0 3 0 6 0
Sicily 39 5.3 5 0.7 6 3 13 0 20 2 45 6.2 7 1.0 7 5 19 1 19 1
Sardinia 9 4.5 1 0.5 3 1 2 0 4 0 10 5.1 1 0.5 4 0 3 0 3 1
Italy 339 4.0 40 0.5 62 28 162 0 116 12 375 4.5 60 0.7 93 38 161 3 120 19
Data were extracted from Hospital Discharge Records; Italian population data were obtained from ISTAT database (www.demo.istat.it)
AFP acute flaccid paralysis, HDR Hospital Discharge Records [5], NSS National Surveillance System [4], IR Incidence rate. ICD-9-CM diagnosis codes: 357.0 “Acute
infective polyneuritis”; 359.9 “Myopathy, unspecified”; 323.9 “Unspecified causes of encephalitis, myelitis, and encephalomyelitis”
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In Italy, data on EV-D68 circulation are not systematic-
ally collected in the context of AFP surveillance.
In Italy, the last case of indigenous poliomyelitis due
to a wild poliovirus occurred in 1982, while in 1988
the last imported case of polio infection was reported.
Polio vaccination became mandatory in 1966 for chil-
dren within the first year of age; in 2002, the inacti-
vated Salk polio vaccine (IPV) completely replaced the
Sabin oral polio vaccine (OPV) for safety reasons and
risk-benefit considerations. The current National Vac-
cination Plan for 2017–2019 includes a primary vac-
cination with three doses at 3, 5, and 11 months of age
and booster doses at 6 and 12–18 years of age [12].
Currently, in the EU area, Bosnia and Herzegovina,
Romania and Ukraine are considered countries with a
high risk of polio outbreak following the importation
of wild PV or emergence of circulating vaccine-
derived PV due to suboptimal vaccination program
performance and low immunity of the population [7].
Furthermore, several middle-income countries were
considered at intermediate risk of polio transmission,
as vaccination coverage appears to be declining and
the quality of poliovirus surveillance is not optimal
[13]. Moreover, in the three remaining endemic coun-
tries, Afghanistan, Pakistan and Nigeria, poliovirus
transmission continued in 2018 [14].
In this scenario, maintaining a high vaccination cover-
age against polio minimizes the risk of spreading the dis-
ease in case of importation, and a highly sensitive
surveillance system for AFP is essential to monitor
polio-free status certification, and to respond to vaccine-
derived polioviruses outbreaks, which could circulate for
several years after ending the use of OPV.
As established by the WHO, at least 1 case of non-
polio AFP should be detected annually per 100,000
population under 15 years of age, which is an adequate
quality of the surveillance system [1]. However, since the
beginning of the NSS, the average value of the non-polio
AFP rate was 0.7 in Italy and reached the target level
only in 2003. Of note, this value is in line with the aver-
age AFP detection rate (0.6/100,000) from 1998 to 2015
in Spain [15]. In this country, the quality of AFP surveil-
lance has decreased over time, particularly after the
switch from OPV to IPV, reflecting the loss of awareness
about polio, when it is very unlikely that cases of par-
alysis produced by wild PV or associated with the
vaccine-derived PV will occur. However, notifications
and hospital admissions with a clinical diagnosis com-
patible with AFP have followed the same pattern, indi-
cating that, despite the underreporting, the surveillance
works relatively well. Overall, in regions certified as
polio-free for many years (the Americas in 1994,
Fig. 1 a-b Acute Flaccid Paralysis by Italian Regions, years 2015–2016. Incidence rates per 100,000 children, data from Hospital Discharge Records
(a); Difference between the number of reported and expected cases, data from the National Surveillance System (b). The maps have been
produced using Stata software, version 13 (Stata Cooperation, College Station, Texas, USA)
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Western Pacific Region in 2000, and WHO European
Region in 2002 [2]), the sensitivity and quality of AFP
reports decreased over time [16].
In our country, several possible reasons have been
identified that contribute to the underreporting in AFP
surveillance system: the long absence of polio in Italy
with consequently loss of interest in preventive issues
and maintainance of polio-free status; the lack of know-
ledge and awareness of clinicians to associate the surveil-
lance with non-polio AFP; the presence of a confirmed
alternative diagnosis. Specifically, some paediatricians
could equate AFP only to acute poliomyelitis and not
with a wide range of conditions that AFP can present,
such as making a specific diagnosis of GBS rather than
labelling a case as AFP. Indeed, the widespread eradica-
tion of poliomyelitis has led to GBS becoming the most
frequent cause of acute and sub-acute flaccid paralysis.
Furthermore, the scarce notification of AFP cases could
be related to the physicians’ lack of knowledge of the
surveillance criteria and of the importance of reporting
and investigating all AFP cases, or finally could be due
to management problems that are much more evident in
some parts of Italy. Overall, several efforts could be
made to enhance and strengthen the surveillance activ-
ities, by increasing awareness of optimal investigation
and management of cases, as well as specific training to
increase knowledge among clinicians, microbiologists,
public health specialists and other key partners involved
in notifiable disease reporting. In addition, laboratory
testing for non-polio enteroviruses could be imple-
mented both to monitor polio eradication and to estab-
lish sensitive surveillance to detect other enteroviruses
that cause severe symptoms such as EV-D68.
Conclusions
Our study shows that the Italian AFP surveillance sys-
tem is affected by underreporting and that the complete-
ness of reporting varies by Italian Regions. Therefore, it
is important to closely monitor the activity of the various
paediatric centres in the country to improve the quality
of the surveillance system. Furthermore, the regular
adoption of the cross-evaluation of notified data, also
through the review of HDRs, could help to plan effective
actions for the improvement of the NSS.
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